Hormone Replacement Therapy (HRT)

Global Market Trajectory & Analytics

MCP-6453

EXECUTIVE ENGAGEMENTS

POOL

8867
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1241
Interactions with Platform & by Email

PARTICIPANTS

266
Unique # Participated

VALIDATIONS

91
Responses Validated*

COMPANIES

47
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

32

PAGES

109

EDITION

17

PRICE

USD 5600

CODE

MCP-6453


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abbott Laboratories, Inc.

AbbVie, Inc.

Acerus Pharmaceuticals Corporation

Acrux Ltd.

Allergan PLC

Amgen Ltd.

Amgen, Inc.

Amneal Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

APS Pharmacy

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.
The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

SELECT PLAYERS

Abbott Laboratories; Allergan Plc; Bayer AG; Novartis AG; Noven Pharmaceuticals Inc.; Novo Nordisk A/S; Pfizer Inc.; TherapeuticsMD Inc.

SEGMENTS

» Segment (Hormone Replacement Therapy (HRT))

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
An Introduction to Menopause and Hormone Replacement Therapy
Recent Market Activity
The HRT Controversy - An Insight
Newer Studies Challenge WHI Findings and Re-establish Safety of HRT
Revised Recommendations of the NAMS and Endocrine Society
IMS Consensus Guidelines Paving Way for More Clarity of HRT
The Regional Divide
Increasing Number of Menopausal Women - A Major Market Driver
New Bioidentical Drugs Serve Unmet Market Needs
Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
Intense Competition Marks the Global HRT Market
The Premarin Saga
Estrace Cream Drives Revenue Gains in Allergan’s HRT Portfolio
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Allergan Plc (Ireland)
Bayer AG (Germany)
Noven Pharmaceuticals, Inc. (USA)
Novartis AG(Switzerland)
Novo Nordisk A/S (Denmark)
Orion Pharma AB (Finland)
Pfizer, Inc. (USA)
TherapeuticsMD, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Unmet Needs in Combination Therapies for HRT drive Research for New Medicines
Topical Estrogens - More Safe and Effective
Transdermal HRT Products Present Exciting Opportunities
Phytoestrogens - The New Panacea for Menopausal Symptoms?
Diet Link to Menopause Symptoms Raises Interest
Impact of Soy and Other Phytoestrogens - A Reality Check
EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms
The Growing Buzz around Bioidentical Drugs
Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT
Direct-to-Consumer Advertising for HRT - A Mixed Bag
Estriol: The Next Generation Estrogen Therapy?
What Makes Estriol Work?
Topical Estriol - More Promising in Safety
Estriol - Used More Commonly Outside the US
Entry of Generics Threatens Market Growth Prospects
Are Non-Hormonal Therapies A Threat to HRT?
Earlier Failures Induce Lethargy in Non-Hormonal Therapies
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
CANADA
Canada Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
JAPAN
Japan Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
CHINA
China Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
EUROPE
Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
GERMANY
Germany Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
ITALY
Italy Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UNITED KINGDOM
UK Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
REST OF EUROPE
Rest of Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
REST OF WORLD
Rest of World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Total Companies Profiled: 47

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com